When Conducting cGMP Regulatory Inspections 2018

Overview:
This webinar will cover the key areas of how ICH Q7 was
established, it's goals and objectives, expectations of the
healthcare authorities involved and practical differences that you
will experience in a GMP inspection of a facility by FDA, an EU
Competent Authority or PMDA.

Why should you Attend:
It has often been stated that "FDA inspects for compliance;
European inspectors inspect for adequate science". Yet GMPs have
been enshrined into law for many countries and a
drug/biologic/medical device manufacturer should have a
reasonable expectation of all inspections being the same. ICH Q7
was established by US / EU and Japan to harmonize inspections in
their respective countries.

Areas Covered in the Session:
Where Inconsistencies Become a Problem: WHO, ICH, Countries
Discrepancies in global expectations
Alignment issues
Key Chapter Reviews
ICH GMP organization
Category reviews

Who Will Benefit:
Manufacturing
Quality Control
Quality Assurance
Senior Management
Project Managers

Speaker Profile: 
Angela Bazigos is the CEO of Touchstone Technologies Inc. She
has degrees in Microbiology and Computing and 40 years of
experience in the Life Sciences, Healthcare & Public Health
Services. Experience combines Quality Assurance, Regulatory
Compliance, Business Administration, Information Technology,
Project Management, Clinical Lab Science, Microbiology, Food
Safety & Turnarounds.

Event Fee: One Dial-in One Attendee Price: US $150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: [email protected]